Standard is a leader in Taiwan generic pharmaceutical market in terms of prescriptions filled, sales volume and value.
Standard is also an emerging leader in Asia Pacific markets and is seeking to rapidly broaden its product portfolio through in-licensing.
The following International markets are of interest to Standard:

Taiwan

Cambodia

Singapore

Mainland China

Indonesia

Thailand

Japan

Malaysia

Vietnam

Korea

Philippines

 
 

Standard is interested in in-licensing finished dosage forms of NCE and generics in CTD format including:
 

Early to market opportunities: Standard has substantial experience in identifying, developing, and registering in early to market opportunities.

(1) first-to-file
(2) non-infringing API and/or formulations

Dosage Forms Standard does not manufacture

Inhalation Dry Powder Inhalers Metered Dose Inhalers
Injectable Depots Hormones Liposomal Pre-filled Syringes
Orals Hormones Buccal/transmucosals
 

Standard offers the following package of services as the licensee/marketer of your product:

Sales and marketing to government and private market segments  

Negotiation with pricing and reimbursement authorities, contracts, bids, tenders

Conduct of bioequivalence studies (if repeat studies against local reference product is required)

Registration and maintenance of Marketing Authorizations

Pharmacovigilance

Supply chain logistics – importation, warehousing and distribution

Packaging – we can take product in either bulk or finished packaged form

Release testing (if required)